Ethnic neutropenia and clozapine

  • Bray A
  • 20

    Readers

    Mendeley users who have this article in their library.
  • 10

    Citations

    Citations of this article.

Abstract

OBJECTIVES: The aim of the present paper was to examine the concept of benign ethnic neutropenia and to consider the implications of ethnicity in the current clozapine regulatory system. METHOD: The case of a young Palestinian man who lost access to clozapine due to a fall in his neutrophil count, is presented herein, and a brief review of ethnic variations in neutrophil levels is given. RESULTS: This patient's clozapine was ceased, with unfortunate consequences, despite his having normal immune function. CONCLUSION: By using normative haematological data established in white populations, the Australian clozapine regulatory system places some non-white patients at a considerable disadvantage.

Author-supplied keywords

  • Clozapine
  • Ethnicity
  • Neutropenia

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Amanda Bray

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free